Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

JPMorgan Chase management disabled comments on an internal webpage where the policy was announced, according to the Wall ...

JPMorgan Chase on Wednesday posted record quarterly and annual earnings and revenue, reinforcing the company’s status as the ...

The bank – the largest in the US with more than 300,000 employees worldwide – is expected to announce the change in the next ...

In a report released yesterday, Mike Mayo from Wells Fargo maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report). The ...

In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm offers a range of investment banking products and ...

JPMorgan Chase & Co. finished off 2024 with a profit that beat analyst estimates as the U.S.'s largest bank reported fourth-quarter earnings of $4.81 a share, well ahead of the FactSet consensus ...

Eight blockbuster drugs are expected to generate over $3bn in peak sales each according to Novartis CEO Vas Narasimhan.

Expected Solana and XRP ETFs could attract sizable investment, JP Morgan analysts said, but it's unlikely they'll match the ...